BIOGAINS LTD

Company number 13159618 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

BIOGAINS LTD - Analysis Report

Company Number: 13159618

Analysis Date: 2025-07-20 14:07 UTC

  1. Risk Rating: HIGH
    The company exhibits significant solvency concerns with negative net assets of £14,402 as of April 2024, no turnover reported, and current liabilities exceeding current assets in prior periods. The continued operating losses and absence of revenue raise substantial doubts about operational sustainability.

  2. Key Concerns:

  • Negative Net Assets and Shareholders’ Funds: The company’s net liabilities position suggests it is insolvent on a balance sheet basis, which is a critical red flag for creditors and investors.
  • No Revenue Generation: Zero turnover over multiple reporting periods indicates a lack of business activity or sales, questioning the viability of the business model and future cash flows.
  • High Long-Term Creditors: The presence of £22,000 creditors due after more than one year relative to minimal current assets points to potential difficulties in meeting obligations as they mature.
  1. Positive Indicators:
  • Timely Filings: The company is current with its accounts and confirmation statement submissions, indicating compliance with regulatory filing requirements.
  • No Director Disqualifications or Insolvency Status: The company is active with no indication of liquidation or administration procedures, and directors appear in good standing.
  • Diverse Ownership Structure: Control is distributed among multiple entities and individuals, which could provide some stability or support depending on their engagement.
  1. Due Diligence Notes:
  • Investigate the nature and terms of the £22,000 long-term creditors to understand repayment obligations and potential refinancing or settlement arrangements.
  • Review management’s plans or business strategy to generate revenue and return to profitability, including any pipeline contracts, funding commitments, or operational changes.
  • Examine cash flow statements and funding sources since no turnover is reported, to assess liquidity and capacity to meet short-term liabilities.
  • Clarify the role and activities leading to ongoing expenses despite zero turnover and no employees, including related-party transactions or capital contributions.

Perspective: Investment Risk Assessor · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.